Therefore, our results indicate that either HIV-1 has evolved to partially circumvent the block imposed by BCA2 (by decreasing BCA2's steady-state levels) or the observed reduction in BCA2 is a side effect of the viral infection, probably due to the activation of additional innate immune pathways that may cause a decrease in BCA2. Here, RNF115 is linked to viral infectious disease.